Evidence map›Paper›PMID 42474359›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Adolescents and Young Adults With Acute Lymphoblastic Leukemia: Qualitative Barriers and Facilitators to Guideline-Concordant Care.

Allison C Grimes, Julie A Wolfson, Charlotte L Kerber, Kristin M Bingen, Melissa P Beauchemin, Koh B Boayue, Jennifer M Levine, Michele A Scialla, Wendy L Woods, Jane J Liu and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Allison C GrimesDivision of Pediatric Hematology-Oncology, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.ORCID 0000-0001-5729-2778
Julie A WolfsonDivision of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Charlotte L KerberDepartment of Public Health Sciences, University of California, Davis, Davis, CA, USA.
Kristin M BingenDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Melissa P BeaucheminSchool of Nursing, Columbia University Irving Medical Center, New York, NY, USA.
Koh B BoayueDivision of Pediatric Hematology-Oncology, University of New Mexico Cancer Center, Albuquerque, NM, USA.
Jennifer M LevineDivision of Pediatric Hematology-Oncology, Children's National Medical Center, Washington, DC, USA.
Michele A SciallaDivision of Pediatric Hematology-Oncology, Nemours, Wilmington, DE, USA.ORCID 0000-0001-7933-0675
Wendy L WoodsDivision of Pediatric Hematology-Oncology, Blank Children's Hospital, Des Moines, IA, USA.ORCID 0000-0002-6280-5360
Jane J LiuOSF Healthcare System, Peoria, IL, USA.
Olivia PonceChildren's Oncology Group, Monrovia, CA, USA.
Sarah L VargasChildren's Oncology Group, Monrovia, CA, USA.
Anjali S AdvaniDepartment of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
George J ChangDepartment of Colon and Rectal Surgery and Department of Health Services Research, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Emily K CurranDivision of Hematology-Oncology, University of Cincinnati, Cincinnati, OH, USA.
Dawn L HershmanDivision of Hematology-Oncology, Columbia University, New York, NY, USA.
Selina M LugerDivision of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Kristen M O'DwyerDivision of Hematology-Oncology, University of Rochester, Wilmot Cancer Institute, Rochester, NY, USA.
Wendy StockDivision of Hematology-Oncology, University of Chicago Medicine, Chicago, IL, USA.
David S DickensDivision of Pediatric Hematology-Oncology, University of Iowa, Iowa City, IA, USA.
Michael E RothDivision of Pediatric Hematology-Oncology, MD Anderson Cancer Center, Houston, TX, USA.
David R FreyerCancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Brad H PollockDepartment of Public Health Sciences, University of California, Davis, Davis, CA, USA.
Lillian SungDivision of Pediatric Hematology-Oncology, The Hospital for Sick Children, Toronto, ON, USA.
Susan K ParsonsDivision of Hematology, Oncology and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
Towards a preventive cancer vaccine for children with constitutional mismatch repair deficiencyUG1CA189955 · NCI · PUBLIC HEALTH INSTITUTE · PI BRAD H POLLOCK, Michael E. Roth · 2014 to 2026
$62.5M
NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCI NIH HHS UG1 CA189823NCI NIH HHS UG1 CA189828NCI NIH HHS UG1 CA189955NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

IntroductionProgress in acute lymphoblastic leukemia (ALL) affecting adolescents and young adults (AYAs), aged 15-39 years, has been challenged by aggressive disease biology, low clinical trial participation, unique supportive care needs, and heterogeneity across treatment settings with lack of age-based standardized therapy. In 2012, the National Comprehensive Cancer Network (NCCN) first issued AYA ALL treatment guidelines. In the absence of formal evaluation of the 2012 NCCN guidelines on the delivery of guideline-concordant care at National Cancer Institute (NCI) Community Oncology Research Program (NCORP) practices, we conducted a qualitative study, as part of the Children's Oncology Group-led cancer care delivery trial ACCL16N1CD.MethodsStructured focus groups, moderated by study members, were convened to identify barriers and facilitators to NCCN guideline-concordant treatment

Indexed as

Guideline AdherencePrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultFemaleFocus GroupsHumansMalePractice Guidelines as TopicQualitative ResearchYoung Adultacute lymphoblastic leukemia (ALL)adolescent and young adult (AYA)guideline concordant carepediatric-inspired therapytreatment guidelines

Identifiers

PMID42474359
PMCPMC13385608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.